Landec Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lifecore Biomedical Inc (LFCR)
The Lifecore Biomedical share price today is 6.53, view NASDAQ LFCR stock exchange data. Track the latest Lifecore Biomedical share price with real-time updates on LFCR stock performance including market cap, day range, 52-week range and dividend yield. Access LFCR charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.53
6.58
52 wk Range
3.63
8.98
LFCR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.536.58
52 wk Range
3.638.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LFCR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
6.28
Downside
-3.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 8K Lifecore Biomedical Inc For: 28 September- Investing.com
Form 13D/A LIFECORE BIOMEDICAL For: 28 September- Investing.com
- Landec Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 13D/A LIFECORE BIOMEDICAL For: 28 September
- Investing.com
- Landec Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
0 Buy
4 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 6.28
(-3.83% Downside)
Lifecore Biomedical Inc Earnings Call Summary for Q2/2026
- Q2 revenue of $34.2M beat estimates by 8% but fell 6.2% YoY; full-year guidance of $120M-$125M revenue and $20.5M-$25M adjusted EBITDA reaffirmed.
- Net loss widened to $6.2M ($0.19/share) from $1.1M ($0.06/share) YoY; adjusted EBITDA declined 5.5% to $8.6M despite cost-cutting progress.
- Liquidity improved to $38.8M with $17.2M cash; SG&A expenses expected to decline to ~$6M quarterly in H2 from current $8M run rate.
- Added six new programs in Q2 with 11 development programs targeting commercialization by end-2028; Alcon demand expected to double in 2027, up 200% in 2028.
- Management projects $7M-$10M full-year free cash flow; Q4-weighted revenue expected with stronger second-half performance driven by existing orders.
Last Updated: 05-08-2026, 06:26 pm
Read Full TranscriptEarnings
Latest Release
31-07-2026
EPS / Forecast
-0.19 / --
Revenue / Forecast
34.17M / --
Compare LFCR to Peers and Sector
Metrics to compare | LFCR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLFCRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.2x | −0.6x | −0.4x | |
PEG Ratio | 0.02 | 0.03 | 0.00 | |
Price/Book | −17.4x | 0.9x | 2.6x | |
Price / LTM Sales | 1.9x | 1.1x | 3.0x | |
Upside (Analyst Target) | −4.6% | 31.7% | 56.4% | |
Fair Value Upside | Unlock | 25.1% | 7.9% | Unlock |
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Lifecore Biomedical (LFCR) Share Price Today?
The Lifecore Biomedical share price today is 6.53.
What is the current Lifecore Biomedical (LFCR) share price and day range?
As of 02-10-2026, the Lifecore Biomedical share price is 6.53, with a previous close of 6.53. The share price has ranged from 6.53 to 6.58 today, while the 52-week range spans from 3.63 to 8.98.
What Is the Lifecore Biomedical Market Cap?
As of today, Lifecore Biomedical market cap is 247.18M.
What Is the Lifecore Biomedical (LFCR) Share Price Target?
The average 12-month share price target for Lifecore Biomedical is 6.28, with a high estimate of 6.28 and a low estimate of 6.28. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and -3.83% Downside potential.
What Is Lifecore Biomedical's Earnings Per Share (TTM)?
The Lifecore Biomedical EPS (TTM) is -0.93.
When Is the Next Lifecore Biomedical Earnings Date?
Lifecore Biomedical will release its next earnings report on 06-11-2026.
From a Technical Analysis Perspective, Is LFCR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Lifecore Biomedical Trade On?
Lifecore Biomedical is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Lifecore Biomedical?
The stock symbol for Lifecore Biomedical is "LFCR."
How Many Times Has Lifecore Biomedical Stock Split?
Lifecore Biomedical has split 0 times.
How Many Employees Does Lifecore Biomedical Have?
Lifecore Biomedical has 382 employees.
What Is the LFCR After Hours Price?
LFCR's last after hours stock price is 6.50, the stock has changed by -0.03, or -0.46%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.